AstraZeneca's Journey to Developing Innovative Content

At AstraZeneca, we've always tried to improve upon the content we create. We're just not thinking about being innovative, but really thinking about how can we meet our HCP's needs and have them understand our information. Dung: The major hurdle has been change management because as many of you know in medical information there have been set ways of working that have, you know, pretty standardized across the industry.